Health

Cleanova Strengthens Filtration Portfolio with Strategic Acquisitions of Airflotek and TES-Clean Air Systems, Entering Ultra-Clean Controlled Environment Markets

CHATTANOOGA, Tenn., Jan. 8, 2026 /PRNewswire/ -- Cleanova, a leading global manufacturer of advanced industrial filtration solutions owned by PX3 Partners, theLondon-headquartered private equity firm, announces today the strategic acquisitions of two U.S.-based companies: Airflotek and TES-Clean ...

2026-01-08 23:30 437

IMG Opens Applications for 2026 Spring Semester 'Student Journey Scholarship'

INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ -- IMG (International Medical Group) is now accepting applications for itsStudent Journey Scholarship

2026-01-08 22:00 482

Telix to Present Pipeline and Commercial Portfolio Overview at J.P. Morgan Healthcare Conference

MELBOURNE, Australia and INDIANAPOLIS, Jan. 8, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today advises that Dr. Christian Behrenbruch, Managing Director and Group CEO, will be presenting at the 44th Annual J.P. Morgan Healthcare Conference being held in Sa...

2026-01-08 19:00 938

From Quantified Meditation to Bio-Computing, All Here Launches the Bio-Intelligence Initiative

GENEVA, Jan. 8, 2026 /PRNewswire/ -- All Here announces the launch of the Bio-Intelligence Initiative, the world's first research program exploring how deep meditative states of stability and silence of Mind give rise to measurable neural patterns, and how these complex neural signatures may insp...

2026-01-08 18:48 877

Ark Biopharmaceutical Receives China Marketing Authorization for Aizhida for the Treatment of ADHD

SHANGHAI, Jan. 8, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced thatChina's National Medical Products Administration (NMPA) has approved the New Drug Application for Serdexmethylphenidate Chloride and Dexmethylphenidate Hydrochloride Capsules (Aizhida) f...

2026-01-08 17:58 1037

Cigna Healthcare Hong Kong Launches Critical Illness Plan to Enhance Health and Financial Protection for Customers

Comprehensive coverage for every stage of the health journey, plus a welcome offer supporting mental health HONG KONG, Jan. 8, 2026 /PRNewswire/ -- Cigna Healthcare Hong Kong today announced the launch of theCigna Healthcare VitalGuard Critical Illness PlanTM (the "Plan"), expanding its medical ...

2026-01-08 17:13 1500

Stay Fit, Stay Well -- The Fitness Industry Is Surging Worldwide

TaiSPO 2026 Pre-registration is Open TAIPEI, Jan. 8, 2026 /PRNewswire/ -- TaiSPO, Taiwan's Sports and Fitness Exhibition, will take place from March 25–28 at Taipei Nangang Exhibition Center Hall 2. Continuing the spirit of "Stay Fit, Stay Well," the event brings key players from the sports, fit...

2026-01-08 12:39 1634

STARMED Unveils New Brand Identity to Drive Global Multi-Modality Strategy

SEOUL, South Korea, Jan. 8, 2026 /PRNewswire/ -- STARMED, a pioneer in innovative minimally invasive treatment solutions, has announced a comprehensive rebranding. Now in its seventeenth year of operation, the company is formally transitioning from a Radiofrequency Ablation (RFA) specialist into ...

2026-01-08 10:41 1527

Sky Labs Secures CE-MDR for 'CART PLATFORM,' Accelerating Its Global Market Entry

- 'CART,' the blood pressure ring, recognized in Europe for its advanced vital sign monitoring technology - Targeting the global healthcare market beyond Europe through CE-MDR certification SEOUL, South Korea, Jan. 8, 2026 /PRNewswire/ -- Sky Labs (CEO Jack Byunghwan Lee) announced on the 8th th...

2026-01-08 09:15 1522

Kolmar Korea Wins CES 2026 Best of Innovation Award in Beauty Tech, a Global First for the Cosmetics Industry

* Proving global competitiveness in beauty tech by capturing the CES "Best of Innovation Award" * AI-powered 'Scar Beauty Device' earns double honors in Beauty Tech and Digital Health categories LAS VEGAS, Jan. 7, 2026 /PRNewswire/ -- Kolmar Korea announced tha...

2026-01-07 21:30 2791

iSMART Developments Ltd Announces Strategic Partnership with L'Oréal Groupe

LONDON, Jan. 7, 2026 /PRNewswire/ -- UK-based skincare, aesthetic and medical device innovator iSMART Developments has announced a strategic partnership with L'Oréal Groupe, marking a significant milestone in the company's long-term growth and leadership within the professional grade light therap...

2026-01-07 17:52 2375

'Scripting Possibilities' in Biotechnology: Global Innovators Converge in San Francisco for GenScript's 5th Annual Biotech Forum During JPM Week

PISCATAWAY, N.J., Jan. 6, 2026 /PRNewswire/ -- GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San Francisco Marriott Marquis, with both in-person and v...

2026-01-06 21:30 2928

Healthcare Holding Schweiz Acquires Stake in Medddbase International

Healthcare Holding Schweiz AG, a leading service provider and distributor of medical technology inSwitzerland, expands its portfolio through the acquisition of a majority stake in Medddbase International AG, which includes Medddbase Schweiz AG and Medddbase Deutschland GmbH. Healthcare Holding Sc...

2026-01-06 19:19 2984

Clarivate Identifies Eleven Potential Blockbuster and Transformative Therapies in its 2026 Drugs to Watch Report

Anticipated advancements in weight loss, diabetes, oncology, rare conditions and protein degraders poised to reshape patient care LONDON, Jan. 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT

2026-01-06 16:21 2637

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

SINGAPORE, Jan. 6, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program.  Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP service...

2026-01-06 12:03 3711

Everest Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference

SHANGHAI, Jan. 6, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced thatIan Woo, President and Chief Fina...

2026-01-06 07:58 2914

BoomerangFX Expands UK and EMEA Operations With New UK Office and Senior Appointments as demand for AI Clinic Co-Pilot AUVIA™ Drives Record Growth in Healthcare

Expansion builds on global offices in Miami, Toronto, London, and Sydney as BoomerangFX advances its mission to become the foundational AI-powered operating platform for private-pay healthcare worldwide. LONDON, Jan. 6, 2026 /PRNewswire/ -- BoomerangFX, a global AI-powered clinic software and ma...

2026-01-06 03:56 2377

Kelun-Biotech Receives Investigational New Drug Approval for ITGB6-Targeted ADC SKB105 from the NMPA

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that its Investigational New Drug (IND) application for SKB105 (also known as CR-003), an internally developed integrin beta-6 (ITGB6)-targeted ant...

2026-01-05 20:00 2781

Sisram Medical Reports Completion of NIFDC Testing for DAXXIFY in China

Marking a Key Milestone Toward Market Launch and Strengthening Sisram's Premium Aesthetics Portfolio HONG KONG, Jan. 5, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the"Group"), a global wellness group off...

2026-01-05 17:36 2236

Kelun-Biotech Announces Breakthrough Therapy Designation Granted in China for Sacituzumab Tirumotecan (sac-TMT) in Combination with Immunotherapy Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC

CHENGDU, China, Jan. 5, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company," 6990.HK) today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT, also known as SKB264/MK-2870) (佳泰莱®) in combination wi...

2026-01-05 17:29 3096
12345 ... 559